Reforming pharmaceutical usage in public health
Context: Pharmaceuticals account for 10 to 30% of public spending for health in most countries. Very large savings can be achieved by improving the selection and quantification of drug requirements.
Implementation: Governments that have introduced competition in the procurement of drugs have typically achieved savings of 40 to 60%. This is aided by developing using national essential drug lists, consisting of a limited number of inexpensive drugs that address the important health problems of the population, and developing country-specific treatment protocols. An essential-drugs revolving fund for several Central American nations yielded savings of 65% of the costs of the pharmaceuticals.
Type Classification: D: Detailed strategies